Mibavademab is a hinge-stabilized human IgG4 monoclonal antibody targeting the leptin receptor (LEPR), produced in CHO cells. It is utilized in research for congenital leptin deficiency, with applications in both in vitro binding assays and in vivo metabolic studies.
Konzentration:
9.628 mg/mL
Molekulargewicht:
~150 kDa
Reinheit:
98.99% (May vary between batches)
CAS Nummer:
[2305770-44-7]
Target-Kategorie:
Neuropeptide Y Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten